DanielGorovetsMD
Radiation Oncology • New York, NYUrologic Cancer
Assistant Attending, Memorial Sloan Kettering Cancer Center
Overview of Dr. Gorovets
Dr. Daniel Gorovets is a radiation oncologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. He received his medical degree from NYU Grossman School of Medicine and has been in practice 5 years. He specializes in urologic cancer and is experienced in genitourinary cancer, prostate cancer, general radiation oncology, proton beam therapy, and radiosurgery.
Office
530 East 74th Street
New York, NY 10021
Education & Training
NYU Grossman School of MedicineResidency, Radiation Oncology, 2013 - 2017- NYU Grossman School of MedicineResidency, Radiation Oncology, 2012 - 2016
Butler Hospital2013 - 2015
Brigham and Women's HospitalInternship, Internal Medicine, 2012 - 2013- New York University School of MedicineClass of 2012
Certifications & Licensure
FL State Medical License 2023 - Present
NY State Medical License 2017 - 2026
NJ State Medical License 2017 - 2025
NC State Medical License 2020 - 2022
MA State Medical License 2012 - 2015
RI State Medical License 2013 - 2015- American Board of Radiology Radiation Oncology
Clinical Trials
- A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer Start of enrollment: 2021 Oct 19
Roles: Principal Investigator, Contact
- A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer Start of enrollment: 2021 Dec 09
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 8 citationsLocal Failure after Prostate SBRT Predominantly Occurs in the PI-RADS 4 or 5 Dominant Intraprostatic Lesion.Daniel Gorovets, Andreas G Wibmer, Assaf Moore, Stephanie Lobaugh, Zhigang Zhang
European Urology Oncology. 2023-06-01 - 5 citationsNovel Treatment Approaches for Locally Advanced Pancreatic CancerDaniel Gorovets, Muhammad Wasif Saif, Kathryn E. Huber
JOP. 2014-03-10 - 204 citationsWhole exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade gliomaKasthuri Kannan, Akiko Inagaki, Joachim Silber, Daniel Gorovets, Jianan Zhang
Oncotarget. 2012-10-11
Professional Memberships
- Member
- Member
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
